Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hyperfine, Inc. (HYPR : NSDQ)
 
 • Company Description   
Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

Number of Employees: 111

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.74 Daily Weekly Monthly
20 Day Moving Average: 209,292 shares
Shares Outstanding: 77.83 (millions)
Market Capitalization: $57.93 (millions)
Beta: 1.04
52 Week High: $1.90
52 Week Low: $0.58
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.51% -3.80%
12 Week -37.97% -32.99%
Year To Date -15.42% -12.11%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
351 NEW WHITFIELD STREET
-
GUILFORD,CT 06437
USA
ph: 866-796-6767
fax: -
webb@gilmartinir.com https://hyperfine.io
 
 • General Corporate Information   
Officers
Maria Sainz - Chief Executive Officer; President and Director
R. Scott Huennekens - Chairperson of the Board
Brett Hale - Chief Administrative Officer; Chief Financial Offi
Jonathan M. Rothberg - Director
John Dahldorf - Director

Peer Information
Hyperfine, Inc. (ABMD)
Hyperfine, Inc. (DMDS)
Hyperfine, Inc. (CPWY.)
Hyperfine, Inc. (EQUR)
Hyperfine, Inc. (ECIA)
Hyperfine, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 44916K106
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/24
Next Expected EPS Date: 05/13/25
Share - Related Items
Shares Outstanding: 77.83
Most Recent Split Date: (:1)
Beta: 1.04
Market Capitalization: $57.93 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.11 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.44 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.11
Price/Cash Flow: -
Price / Sales: 4.49
EPS Growth
vs. Year Ago Period: 6.67%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -13.59%
vs. Previous Quarter: -36.29%
ROE
03/31/25 - -
12/31/24 - -65.21
09/30/24 - -57.54
ROA
03/31/25 - -
12/31/24 - -56.10
09/30/24 - -50.38
Current Ratio
03/31/25 - -
12/31/24 - 6.15
09/30/24 - 6.44
Quick Ratio
03/31/25 - -
12/31/24 - 5.48
09/30/24 - 5.73
Operating Margin
03/31/25 - -
12/31/24 - -315.90
09/30/24 - -309.42
Net Margin
03/31/25 - -
12/31/24 - -315.90
09/30/24 - -309.42
Pre-Tax Margin
03/31/25 - -
12/31/24 - -315.90
09/30/24 - -309.42
Book Value
03/31/25 - -
12/31/24 - 0.67
09/30/24 - 0.80
Inventory Turnover
03/31/25 - -
12/31/24 - 1.01
09/30/24 - 1.01
Debt-to-Equity
03/31/25 - -
12/31/24 - 0.00
09/30/24 - 0.00
Debt-to-Capital
03/31/25 - -
12/31/24 - 0.00
09/30/24 - 0.00
 

Powered by Zacks Investment Research ©